Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on Insulin in Combination With Metformin in Type 2 DM (ZEUS II Study)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 290 participants.

Also called NCT02831361

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 290 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02831361
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02831361. Randomized; double masking; primary purpose treatment. Start 2016-10-17 (actual); primary completion 2018-02-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on Insulin in Combination With Metformin in Type 2 DM (ZEUS II Study)
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
Gemigliptin
Intervention (Drug)
Gemigliptin placebo
Intervention (Drug)
Metformin
Intervention (Procedure)
Diet/exercise questionnaire
Lead sponsor
LG Life Sciences (class: industry)

Record details

Record id
cardio:ct-nct02831361
Content hash
7dea750c085b67c5d6bd5a6afe3d9b775005b804409930385f1cb6f664ba2d6d